NL-OMON46446已完成不适用
sability, Reliability and Preliminary Efficacy of a Smartphone App for Patients with Intermittent Claudication - Claudication App Pilot
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •- Diagnosis of intermittent claudication (symptomatic peripheral arterial disease, Rutherford stage 1-3, Fontaine 2a-2b) evidenced by a resting ankle-brachial index of *0.9 in rest and/or a drop of >0.15 after treadmill walking in either leg.
- •- In possession of a smartphone capable of running the intervention application.
- •- A signed informed consent form.
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •- Supervised exercise therapy, performed in accordance with the guidelines of the Dutch Society of Physical Therapy, in the 12 months prior to study enrolment.
- •- The ability to finish the Gardner Skinner treadmill test (i.e. walk for >30 minutes, or >1600 meters).
- •- Severely limited ambulation due to a cause other than intermittent claudication (e.g. above or below the knee amputation, critical limb ischemia, wheelchair confinement, foot ulcer, significant visual impairment, unstable angina, heart failure NYHA class II or greater, COPD GOLD 3-4) and/or the inability to frequent the physical therapy centre at the expected visit frequency.
- •- Deemed a poor candidate for inclusion at the discretion of the physical therapist or principal investigator.
研究者
相似试验
尚未招募
2 期
Evaluation of the effect of microneedling with tranexamic acid in combination with hydroquinone formula in comparison with either alone in the treatment of melasmaChloasmaIRCT20220122053789N1Iran University of Medical Sciences50
招募中
2 期
The efficacy, safety, and the predictive factors of efficacy of low dose Lenalidomide plus Dexamethasone consolidation therapy followed by very low dose Lenalidomide maintenance therapy for multiple myeloma.multiple myelomaJPRN-UMIN000007785ational Hospital Organization Disaster Medical Center35
招募中
不适用
The efficacy, safety, and the predictive factors of efficacy of Bird therapymultiple myelomaJPRN-UMIN000013959ational Hospital Organization Disaster Medical Center35
已完成
1 期
The safety, efficacy and the predictive factors of efficacy of beclomethasone dipropionate (BDP) for acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantatioHematologic disorders gastrointestinal acute GVHDJPRN-UMIN000007439Hematology,Graduate School of Medicine, Osaka City University26
进行中（未招募）
1 期
Phase 2b study evaluating efficacy, safety and tolerability of study drug called NGM282 (Aldafermin) in Patients with Compensated Cirrhosis Due to Nonalcoholic SteatohepatitisCompensated Cirrhosis Due to Nonalcoholic SteatohepatitisMedDRA version: 22.0Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersMedDRA version: 20.1Level: LLTClassification code 10064844Term: Compensated cirrhosisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2019-002341-38-FRGM Biopharmaceuticals, Inc.150